You've probably heard of a condition called rosacea, but did you know that it can affect the eyes? Rosacea is a condition that commonly affects the nose, face, and chest. Rosacea can be chronic and ...

Tarsus Pharmaceuticals' lotilaner shows strong market performance for Demodex blepharitis, but cautious investment due to ...

If you have persistent or recurrent discoloration (change in the natural skin tone) on your face, an appearance of tiny superficial blood vessels on your cheeks and forehead, or dry, bloodshot eyes, ...

Medically reviewed by William Truswell, MD Pores are small openings in the skin that contain hair and sebum (oil) glands.

W ouldn't it be great to sail through the rest of winter with soft skin? For the 78 percent of us bothered by itchy or sore ...

If you buy something, we may earn an affiliate commission. If you have rosacea, you’re probably all too familiar with red cheeks and sensitive, irritated skin. The condition might also cause ...

Rosacea might not be the most talked about skin condition (we’re giving that crown to acne), but it doesn’t mean it’s not affecting a lot of us. According to Patient UK, one in 20 people in ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Combination birth control pills, or the pill for short, are oral contraceptives that prevent pregnancy. If you’re considering your birth control options, the pill is one of the most common and ...

Taking birth control pills is pretty easy — you just pop a tiny pill into your mouth and swallow. There are two different types of birth control pills: combination pills (estrogen and progestin ...

Deucravacitinib is under clinical development by Bristol-Myers Squibb and currently in Phase II for Rosacea. According to GlobalData, Phase II drugs for Rosacea have a 38% phase transition success ...

While the natural aging of the skin and body is inevitable, experts suggest that excessive intake of certain supplements can speed up this process after the age of 40. Robert Love, a neuroscientist ...